Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression

Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy

(2016) R. Moschoi et al.   BLOOD

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

(2016) Susan A. Burchill et al.   CANCER

Mitochondria and Cancer

(2016) Sejal Vyas et al.   CELL

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma

(2016) Daniela Formicola et al.   Journal of Translational Medicine

Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells

(2016) Liz J. Valente et al.   Cell Reports

Neuroblastoma

(2016) Katherine K. Matthay et al.   Nature Reviews Disease Primers

The complex role of SIRT6 in carcinogenesis

(2015) Batia Lerrer et al.   CARCINOGENESIS

Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study

(2015) Fikret Rifatbegovic et al.   PLoS One

Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen

(2015) Martin Michaelis et al.   Scientific Reports

HTSeq--a Python framework to work with high-throughput sequencing data

(2014) S. Anders et al.   BIOINFORMATICS

Recent insights into the biology of neuroblastoma

(2014) Gudrun Schleiermacher et al.   INTERNATIONAL JOURNAL OF CANCER

Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses

(2014) M. Reza Abbasi et al.   Molecular Oncology

Mechanisms of neuroblastoma regression

(2014) Garrett M. Brodeur et al.   Nature Reviews Clinical Oncology

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma

(2013) H Kocak et al.   Cell Death & Disease

Regulation of Bone Marrow Angiogenesis by Osteoblasts during Bone Development and Homeostasis

(2013) Ernestina Schipani et al.   Frontiers in Endocrinology

RSeQC: quality control of RNA-seq experiments

(2012) Liguo Wang et al.   BIOINFORMATICS

The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism

(2012) Carlos Sebastián et al.   CELL

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

(2012) Jan J. Molenaar et al.   NATURE

Bone Marrow-Infiltrating Human Neuroblastoma Cells Express High Levels of Calprotectin and HLA-G Proteins

(2012) Fabio Morandi et al.   PLoS One

The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma

(2011) J. Stutterheim et al.   EUROPEAN JOURNAL OF CANCER

Fast and SNP-tolerant detection of complex variants and splicing in short reads

(2010) T. D. Wu et al.   BIOINFORMATICS

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

(2010) André Oberthuer et al.   JOURNAL OF CLINICAL ONCOLOGY

Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme

(2010) Kristian Ovaska et al.   Genome Medicine

Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence

(2009) T. M. Morgan et al.   CLINICAL CANCER RESEARCH

Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers

(2009) J. Stutterheim et al.   CLINICAL CHEMISTRY

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

(2009) Joëlle Vermeulen et al.   LANCET ONCOLOGY

Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma

(2008) I. Y. Cheung et al.   CLINICAL CANCER RESEARCH

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

(2008) Susan L. Cohn et al.   JOURNAL OF CLINICAL ONCOLOGY

Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions

(2008) K. De Preter et al.   NUCLEIC ACIDS RESEARCH

Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas

(2008) Frank Westermann et al.   GENOME BIOLOGY